Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial

Summary: Background: BCG vaccination prevents severe childhood tuberculosis (TB) and was introduced in South Africa in the 1950s. It is hypothesised that BCG trains the innate immune system by inducing epigenetic and functional reprogramming, thus providing non-specific protection from respiratory...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Caryn M. Upton, Rob C. van Wijk, Laurynas Mockeliunas, Ulrika S.H. Simonsson, Kirsten McHarry, Gerben van den Hoogen, Chantal Muller, Arne von Delft, Helene-Mari van der Westhuizen, Reinout van Crevel, Gerhard Walzl, Pedro M. Baptista, Jonathan Peter, Andreas H. Diacon
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Elsevier 2022-06-01
Saila:	EClinicalMedicine
Gaiak:	COVID-19 BCG Respiratory tract infection Vaccine Tuberculosis Trained immunity
Sarrera elektronikoa:	http://www.sciencedirect.com/science/article/pii/S2589537022001444
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!